Does SELUMETINIB Cause Decreased appetite? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Decreased appetite have been filed in association with SELUMETINIB (KOSELUGO). This represents 1.5% of all adverse event reports for SELUMETINIB.
18
Reports of Decreased appetite with SELUMETINIB
1.5%
of all SELUMETINIB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Decreased appetite From SELUMETINIB?
Of the 18 reports, 5 (27.8%) required hospitalization, and 2 (11.1%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for SELUMETINIB.
What Other Side Effects Does SELUMETINIB Cause?
Blood creatine phosphokinase increased (105)
Rash (89)
Off label use (78)
Paronychia (73)
Dermatitis acneiform (61)
Diarrhoea (59)
Fatigue (54)
Acne (52)
Nausea (49)
Death (47)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which SELUMETINIB Alternatives Have Lower Decreased appetite Risk?
SELUMETINIB vs SEMAGLUTIDE
SELUMETINIB vs SEMUSTINE
SELUMETINIB vs SENNA LEAF
SELUMETINIB vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B
SELUMETINIB vs SENNOSIDES